Global Women's Health Market Growth (Status and Outlook) 2025-2031

The global Women's Health market size is predicted to grow from US$ 35900 million in 2025 to US$ 45550 million in 2031; it is expected to grow at a CAGR of 4.0% from 2025 to 2031.

Women's health refers to the branch of healthcare that focuses on the unique medical needs of women throughout different stages of life, from puberty to menopause and beyond. It includes a wide range of conditions and treatments related to reproductive health, hormonal imbalances, pregnancy, breast health, osteoporosis, and mental well-being. Women's health also covers issues like sexual health, contraception, fertility, and gynecological diseases such as endometriosis and polycystic ovary syndrome (PCOS). Recognizing that women experience health issues differently than men, this field emphasizes gender-specific research and treatments tailored to the physiological, psychological, and social needs of women.

Market Driver: The increasing focus on women’s health, driven by a combination of greater awareness, advocacy, and healthcare advancements, is a major driver of the women’s health market. As women continue to seek more personalized and comprehensive care, demand for treatments addressing conditions like reproductive health, menopause, osteoporosis, breast cancer, and mental health is on the rise. This is further supported by the growing recognition of the need for gender-specific healthcare solutions, including pharmaceuticals, diagnostics, and wellness products. Additionally, the rise in women’s life expectancy and the increasing number of women in the workforce who are able to access healthcare resources have also contributed to the growth of this market.

Market Challenge: Despite the growing demand for women’s health products and services, the market faces several challenges, including underrepresentation of women in clinical research and the lack of tailored treatments for gender-specific health issues. Many medical studies have historically been conducted with a male-dominated sample, which leads to insufficient data on how treatments affect women differently. Moreover, there are still significant social and cultural barriers in certain regions that prevent women from accessing adequate healthcare or seeking treatments for issues like reproductive health or menopause. These challenges can slow market growth, limit access, and hinder the development of more effective and personalized care for women.

The main companies of Global Women's Health include Amgen, Bayer, Merck KGaA, etc. These top three companies hold a market share about 20%. Europe and North America are the leading production regions in the world. The product is mainly used in contraceptive pills.

LPI (LP Information)' newest research report, the “Women's Health Industry Forecast” looks at past sales and reviews total world Women's Health sales in 2024, providing a comprehensive analysis by region and market sector of projected Women's Health sales for 2025 through 2031. With Women's Health sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Women's Health industry.

This Insight Report provides a comprehensive analysis of the global Women's Health landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Women's Health portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Women's Health market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Women's Health and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Women's Health.

This report presents a comprehensive overview, market shares, and growth opportunities of Women's Health market by product type, application, key players and key regions and countries.

Segmentation by Type:
Hormone Therapy
Nonhormonal Therapy

Segmentation by Application:
Climacteric
Postmenopausal Osteoporosis
Contraceptive Pill
Infertility
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Amgen
Bayer
Merck KGaA
Merck & Co
Ferring
Eli Lilly
Pfizer
AbbVie
Abbott
Theramex
Livzon Pharmaceuticals
Foundation Consumer Healthcare
Xianjun Pharmaceuticals
Zizhu Pharmaceuticals
Qianjin Pharmaceuticals
Organon Pharma
Insud Pharma
Viatris
Teva
Hisamitsu

Please note: The report will take approximately 2 business days to prepare and deliver.